In parallel, We used GSK-J4 to inhibit KDM6B in ESCC cells, and ChIP-qPCR also found that inhibiting KDM6B can significantly reduce the expression level of H3K27me3 in the C/EBPβ promoter region (Fig. 4k). This evidence concerns the gene KDM6B and esophageal squamous cell carcinoma.